Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 923093 STAMFORD, CT

Position in EWTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,313,228
+$1,371,725 QoQ
Shares Held
56,934
+90.5% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#87
of 223 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in EWTX Over Time

Shares Held

Position Value (USD)

Derivatives in EWTX

reported options exposure · as of Dec 31, 2025
CallValue
$871,006
CallShares
35,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names. EWTX ranks #31 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EWTX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,313,228 56,934
2026-03-31 $941,503 29,889
2025-12-31 $871,006 35,100
2025-09-30 $627,714 38,700
2025-06-30 $546,201 41,663
2025-03-31 $1,029,688 46,804
2024-12-31 $1,169,700 43,809
2024-09-30 $950,510 35,613
2024-06-30 $475,644 26,410